Global News

AIDS Healthcare Foundation acquires MOMS Pharmacy

Wednesday, August 22, 2012 10:44 AM

AIDS Healthcare Foundation (AHF), a global nonprofit HIV/AIDS organization has acquired MOMS Pharmacy, a specialty pharmacy focused exclusively on providing medications and support services to people living with HIV/AIDS.

More... »

South and Central America API market closing gap on northern neighbors

Wednesday, August 22, 2012 09:57 AM

More... »

Ipsen, Inspiration Biopharmaceuticals renegotiate strategic partnership

Tuesday, August 21, 2012 12:15 PM

Ipsen, a global specialty-driven pharmaceutical company, has renegotiated its 2010 strategic partnership agreement with Inspiration Biopharmaceuticals, a Cambridge, Mass.-based biopharmaceutical company focused on hemophilia, for the development and commercialization of Inspiration’s recombinant product portfolio.

More... »

Allergan, Molecular Partners form two exclusive alliances in eye disease

Tuesday, August 21, 2012 10:24 AM

Allergan, a multi-specialty health care company based in Medford, Mass., and Molecular Partners, a privately-owned Swiss biotech focused on a class of biological drugs known as DARPins, have significantly expanded their existing relationship by entering into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.

More... »

Almac launches next generation sequencing service for personalized medicine

Tuesday, August 21, 2012 09:10 AM

Global service provider Almac is launching a next generation sequencing (NGS) service to further expand its range of solutions supporting the development of personalized medicine.

More... »

Adventrx names Vetticaden as chief medical officer

Monday, August 20, 2012 04:01 PM

Adventrx Pharmaceuticals, a biopharmaceutical company based in San Diego, has appointed Santosh J. Vetticaden, M.D., Ph.D., as chief medical officer and senior vice president.

More... »

Breast cancer drug market will be driven by 3 agents, says Decision Resources

Monday, August 20, 2012 02:18 PM

Three new breast cancer market entrants—Roche/Genentech’s Perjeta (pertuzumab) and trastuzumab-DM1 (T-DM1), and Novartis’s Afinitor (everolimus)—will drive growth in the breast cancer market through 2021, according to Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues.

More... »

Thirty teams compete to interpret three families' genomes

Monday, August 20, 2012 12:08 PM

In a contest led by Boston Children's Hospital, 30 teams from around the world are vying to interpret the DNA sequences of three children with rare conditions whose cause remains a mystery—with the goal of establishing "best practices" for interpreting genomic data.

More... »

United Drug acquires Bilcare’s clinical trials materials business

Monday, August 20, 2012 11:51 AM

United Drug, an international provider of healthcare services, will acquire the U.K. and U.S. clinical services businesses (combined "Bilcare Global Clinical Supplies" or "Bilcare GCS") from Bilcare Limited for $61 million. The acquisition is expected to be completed on Aug. 31. Bilcare will retain its clinical supplies business in Asia.

More... »

HUYA Bioscience, Tianjin Research Center form collaboration

Monday, August 20, 2012 10:03 AM

HUYA Bioscience International, focused on accelerating the global development of China’s pharmaceutical innovations, has formed a strategic partnership with Tianjin Research Center of Basic Medical Sciences (TJRCBMS), a nonprofit Chinese research institution.

More... »